Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy
商品説明・詳細
送料・お届け
商品情報
Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy,Frontiers | MSC exosomes attenuate sterile inflammation and necroptosis associated with TAK1-pJNK-NFKB mediated cardiomyopathy in diabetic ApoE KO mice,The Union Democrat 07-09-2015 by Union Democrat - Issuu,E 9 55 hi-res stock photography and images - Page 8 - Alamy,Machinery Trader